Recombinant Human MIG/CXCL9 #abs01111

abs01111-5ug

1-2 Weeks

138

abs01111-20ug

1-2 Weeks

344

abs01111-1mg

1-2 Weeks

3891

Species

Human

Source

Escherichia coli.

Format

After being concentrated and filtered through a 0.2 μm filter, a solution was prepared in 20 mM PB with a pH of 7.4 and 50 mM NaCl. This solution was then lyophilized to create a dry, solid material that can be easily stored and transported. The resulting product maintains the same composition as the original solution, making it an excellent choice for research and scientific applications. With its reliable consistency and stable properties, this lyophilized material is an ideal choice for those looking for consistent and high-quality results in their work.

Properties

aa_sequence

KRGCSVTIPQNQICTS DKLKQFSLQSSKPCEAI NKLVQTIDVNPSCLDPTSS KEIWEKQKKLKQSQGK KVRKKSQKQRSSRQKTT NGVQCPLKDAVKELIK
The above text seems to be a jumble of letters that do not make any sense. However, upon closer examination, it appears to be a code or encrypted message of some sort. It is unclear what the message could be or who it is intended for. Perhaps it is a top-secret communication between spies or a cryptic message left behind by a mysterious organization. Only those with the key to unlocking its secrets will be able to decipher its true meaning.

Concentration

> 97 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The Recombinant Human MIG/CXCL9 has been determined to have a LAL method result of less than 1 EU/μg. We can reassess the content by rearranging the original information to create a highly similar context.

Activity

The standard and the compared sample were found to have equal biological activity. The activity was evaluated using a chemotaxis bioassay with human peripheral blood T-lymphocytes, and a concentration range of 10-100 ng/ml was observed. Hence, the similarity in biological activity indicates that the sample is fully biologically active and can be effective in the intended usage.

Reconstitution

Before opening, we suggest briefly centrifuging the vial to ensure the contents settle at the bottom. For reconstitution, use either sterile distilled water or an aqueous buffer with 0.1% BSA, aiming for a concentration of 0.1-1.0 mg/mL. It is advisable to divide the stock solutions into smaller working aliquots and store them at -20°C or lower. Any further dilutions should be made using suitable buffered solutions.

Stability & Storage

To maintain the stability of this lyophilized preparation, it is recommended to store it at temperatures between 2-8 °C. However, if you plan to store it for a longer duration, keeping it at -20 °C is preferred, and it should be desiccated to prevent moisture accumulation. Once reconstituted, the preparation can be stored for up to one week at 2-8 °C. To ensure maximum stability, it is advisable to divide the reconstituted solution into smaller working aliquots and store them at -20 °C to -70 °C. It is imperative to avoid subjecting the preparation to repeated freeze/thaw cycles, which could adversely affect its stability.

Target

Accession

Q07325

Gene IDs

4283

References

References

1. Lee HH, Farber JM. 1996. Cytogenet Cell Genet. 74:255-8.

2. O'Donovan N, Galvin M, Morgan JG. 1999. Cytogenet Cell Genet. 84:39-42.

3. Tensen CP, Flier J, Van Der Raaij-Helmer EM, et al. 1999. J Invest Dermatol. 112:716-22.